BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28677533)

  • 1. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
    Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
    Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene.
    Bolinches-Amorós A; Lukovic D; Castro AA; León M; Kamenarova K; Kaneva R; Jendelova P; Blanco-Kelly F; Ayuso C; Cortón M; Erceg S
    Stem Cell Res; 2018 Apr; 28():96-99. PubMed ID: 29453128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
    Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
    Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an iPS cell line via a non-integrative method using urine-derived cells from a patient with USH2A-associated retinitis pigmentosa.
    Guo Y; Zeng Q; Liu S; Yu Q; Wang P; Ma H; Shi S; Yan X; Cui Z; Xie M; Xue Y; Zha Q; Li Z; Zhang J; Tang S; Chen J
    Stem Cell Res; 2018 May; 29():139-142. PubMed ID: 29660607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
    Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
    Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
    Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of mutation in SACSIN gene.
    Machuca C; Vilches A; Clemente E; Pascual-Pascual SI; Bolinches-Amorós A; Artero Castro A; Espinos C; Leon M; Jendelova P; Erceg S
    Stem Cell Res; 2018 Dec; 33():166-170. PubMed ID: 30384130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene.
    Arellano CM; Vilches A; Clemente E; Pascual-Pascual SI; Bolinches-Amorós A; Castro AA; Espinos C; Rodriguez ML; Jendelova P; Erceg S
    Stem Cell Res; 2018 Aug; 31():249-252. PubMed ID: 30144656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of non-integrate induced pluripotent stem cell line CSUASOi006-A, from urine-derived cells of a PRPF8-related dominant retinitis pigmentosa patient.
    Zhou Y; Cui Z; Jing Y; Mao S; Chen D; Ding C; Gu J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 Dec; 49():102041. PubMed ID: 33157387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy.
    Erkilic N; Sanjurjo-Soriano C; Diakatou M; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2019 Jul; 38():101478. PubMed ID: 31203166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
    Li YP; Liu H; Jin ZB
    Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.